JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1)
Exhibit 1
| CUSIP NO. 00000X000 | Schedule 13D | Page 20 of 20 |
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1)
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the
persons named below agree to the joint filing on behalf of each of them of the Schedule 13D to
which this Agreement is an exhibit (and any further amendment filed by them) with respect to the
shares of Common Stock of Aegerion Pharmaceuticals, Inc. This agreement may be executed
simultaneously in any number of counterparts, all of which together shall constitute one and the
same instrument.
Advent Healthcare and Life Sciences III Limited Partnership
Advent Healthcare and Life Sciences III A Limited Partnership
Advent Healthcare and Life Sciences III A Limited Partnership
By:
|
AHLS III GP Limited Partnership, General Partner | |
By:
|
Advent International LLC, General Partner | |
By:
|
Advent International Corporation, Manager | |
By:
|
Xxxxxxx X. Xxxxxx, Compliance Officer* | |
| Advent Partners HLS III Limited Partnership | ||
By:
|
Advent International Corporation, General Partner | |
By:
|
Xxxxxxx X. Xxxxxx, Compliance Officer* | |
| AHLS III GP Limited Partnership | ||
By:
|
Advent International LLC, General Partner | |
By:
|
Advent International Corporation, Manager | |
By:
|
Xxxxxxx X. Xxxxxx, Compliance Officer* | |
| Advent International LLC | ||
By:
|
Advent International Corporation, Manager | |
By:
|
Xxxxxxx X. Xxxxxx, Compliance Officer* | |
| Advent International Corporation | ||
By:
|
Xxxxxxx X. Xxxxxx, Compliance Officer* | |
* For all of the above:
/s/ Xxxxxxx X. Xxxxxx
|
